Results for 'Gastrointestinal Cancers'

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Apr 7th • 12 mins read

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Feb 22nd • 10 mins read

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
Sep 27th • 1 min read

Loose Regulatory Standards Portend a New Era of Imprecision Oncology
Dec 1st • 4 mins read

Seven decades of chemotherapy clinical trials: a pan-cancer social network analysis
Oct 16th • 12 mins read

Advances and Challenges in Pediatric and Childhood Cancers
Jun 27th • 2 mins read

A Field Test of Major Value Frameworks in Chemotherapy of Nasopharyngeal Carcinoma-To Know, Then to Measure
Aug 12th • 10 mins read

Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration
Aug 31st • 16 mins read

Comparison of Access to Novel Drugs for Lymphoma and Chronic Lymphocytic Leukemia Between India and the United States
Jul 21st • 12 mins read

Precision medicine for pediatric cancers lags behind that for adult cancers: Citing hurdles in clinical trial recruitment and drug development, researchers are exploring ways to close gaps
Jan 9th • 2 mins read

Outcome measures for oncology alternative payment models: practical considerations and recommendations
Dec 1st • 10 mins read

Mandatory Research Biopsy Requirements Delay Initiation of Clinical Trials
Oct 18th • 10 mins read

Pivotal Considerations for Optimal Deployment of Healthy Volunteers in Oncology Drug Development
Oct 31st • 20 mins read

Association of National Cancer Institute-Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications
Sep 4th • 17 mins read


Biosimilars in Oncology: Latest Trends and Regulatory Status
Dec 5th • 20 mins read


Patient involvement: A must-have in medicine development, but is it being overlooked in a cost-constrained environment?
May 9th • 5 mins read

Value assessment of PD-1/PD-L1 inhibitors in the treatment of esophageal and gastrointestinal cancers
Apr 21st • 13 mins read

Application of Value Framework to Phase III Trials of Immune Checkpoint Inhibitors in Esophageal and Gastric Cancer
Jan 13th • 8 mins read

Report from American Society of Clinical Oncology Symposium 2020 and American Society of Clinical Oncology Gastrointestinal Cancer Symposium 2021
Aug 4th • 13 mins read